Hikal Ltd.
Hikal Ltd. is an Indian publicly-listed CDMO founded in 1988 that manufactures APIs, intermediates, crop protection chemicals, and specialty chemicals for global pharmaceutical and agrochemical innovator companies across five manufacturing facilities and a Pune R&D centre.
- Company typePublic
- Founded1988
- HeadquartersSeattle, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hikal Ltd. does
Hikal Ltd. is an Indian publicly-listed (NSE/BSE ticker: HIKAL) fine chemicals and contract development and manufacturing organization (CDMO) founded in 1988 and headquartered in Navi Mumbai, with operations spanning pharmaceuticals, crop protection, and specialty chemicals. The company operates five manufacturing facilities — Jigani Units 1 and 2 (Karnataka), Panoli (Gujarat), Mahad (Maharashtra), and Taloja (Maharashtra) — with a combined reactor capacity of 4,100 M3, supported by a Research and Technology centre in Pune housing 250+ post-graduates, 26 PhDs, and an HPAPI laboratory. Hikal manufactures active pharmaceutical ingredients (APIs), intermediates, animal health products, and crop protection chemicals (insecticides, fungicides, herbicides, biocides) primarily for global pharmaceutical innovator and crop protection companies, with additional specialty chemical custom manufacturing.
The company generates revenue via custom synthesis contracts and CDMO services priced on a project-by-project, multi-year basis with global enterprise customers in pharma, crop protection, biotech, agrochemicals, and specialty chemicals. Pharmaceuticals and crop protection are the primary revenue divisions; animal health (entered 2007) and specialty chemicals are smaller. Hikal invests 4–5% of sales in R&D (INR 806M in FY24, with 13 patent applications filed), and emphasizes US FDA approvals, green chemistry (61.7% renewable energy in FY24), and ESG practices. Recent strategic initiatives include Project Pinnacle 2.0 (operational excellence) and a new Animal Health manufacturing facility at Panoli; however, the company has experienced revenue and margin decline from FY23 to FY26 and faces regulatory headwinds from a USFDA warning letter on its Jigani facility issued in August 2025.
Hikal Ltd. firmographics
Firmographics- Name
- Hikal Ltd.
- Legal name
- HIKAL Ltd.
- Website
- https://hikal.com
- Company type
- Public
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Hikal Ltd. is an Indian publicly-listed CDMO founded in 1988 that manufactures APIs, intermediates, crop protection chemicals, and specialty chemicals for global pharmaceutical and agrochemical innovator companies across five manufacturing facilities and a Pune R&D centre.
- Ownership category
- akta.pro rank
Hikal Ltd. industry classification
Industry- Product category
- Pharmaceutical CDMO and Crop Protection Manufacturing
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pesticide and Other Agricultural Chemical Manufacturing (32532), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)
- akta.pro primary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
- akta.pro secondary industries
- Custom Synthesis & Technical Active Ingredient (AI) Manufacturing (intermediates, actives) (AFABAIAI), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
Keywords
Where Hikal Ltd. is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Hikal Ltd. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Division: Manufacturing and sale of APIs (Active Pharmaceutical Ingredients) and intermediates for human health and animal health. Includes contract development and manufacturing services (CDMO) for global pharmaceutical companies.
- Crop Protection Division: Manufacturing and sale of insecticides, fungicides, herbicides, biocides, and intermediates for agricultural industry.
- Specialty Chemicals: Custom manufacturing solutions for specialty chemicals industry.
- Contract Research Services: R&D and contract research services provided to pharmaceutical and life sciences companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom manufacturing contracts |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Hikal Ltd. product offering
Product offeringCore offering
Hikal manufactures and supplies active pharmaceutical ingredients (APIs), advanced intermediates, and crop protection chemicals (insecticides, fungicides, herbicides, biocides) for global pharmaceutical, agrochemical, and specialty chemicals companies. The company also provides contract development and manufacturing (CDMO) services, animal health APIs/intermediates, and custom synthesis solutions through five manufacturing facilities and a dedicated Research & Technology centre.
Product overview
Hikal Ltd. is a diversified fine chemical company operating across Pharmaceuticals, Crop Protection, and Specialty Chemicals divisions. The company offers a portfolio of products including active pharmaceutical ingredients (APIs), intermediates, contract development and manufacturing (CDMO) services, animal health products, crop protection chemicals (insecticides, fungicides, herbicides, biocides), and specialty chemicals. The Pharmaceuticals Division provides APIs, intermediates, and CDMO services for human and animal health; the Crop Protection Division delivers insecticides, fungicides, herbicides, and intermediates; the Specialty Chemicals Division offers custom manufacturing solutions. The Research & Technology center supports product development across all divisions, and Project Pinnacle 2.0 serves as the company's strategic transformation initiative.
Differentiator
Problem solved
Functional benefit
Brands
- Project Pinnacle: Strategic transformation initiative launched in 2022 to achieve growth targets and operational excellence.
- HiBEX
Products and services
- Pharmaceuticals Division Provides active pharmaceutical ingredients (APIs), intermediates, contract development and manufacturing (CDMO) services, and animal health products for global pharmaceutical companies serving human and animal health applications.
- Crop Protection Division Provides crop protection products including insecticides, fungicides, herbicides, biocides, and intermediates for global agricultural industry companies.
- Specialty Chemicals Delivers custom manufacturing solutions for the specialty chemicals industry serving various sectors with tailored chemical products.
- Research & Technology Services R&D services, process development, and innovation support for pharmaceuticals, crop protection, and specialty chemicals divisions, backed by a Scientific Advisory Board of globally renowned chemists.
- APIs and Intermediates Manufacturing of active pharmaceutical ingredients and advanced intermediates for global pharmaceutical innovator companies, including complex chiral chemistry and conventional synthesis capabilities.
- Contract Development & Manufacturing (CDMO) Contract research and custom synthesis services for pharmaceutical companies, supporting scale-up from gram to tonne quantities with end-to-end development and manufacturing capabilities.
- Animal Health APIs and Intermediates Animal health APIs and intermediates for farm and companion animal segments, manufactured from GMP-compliant facilities including 10+ animal health focused APIs and 4+ existing relationships with animal health innovators.
Quantifiable outcome
- Revenue of INR 17,870 million in FY24
- +6 more outcomes
Companies that use Hikal Ltd.
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Hikal Ltd. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Hikal Ltd. partnerships and signals
Strategic signalScale indicators20 records
Recent moves6 records
Expansion highlights5 records
Hikal Ltd. competitors and assessment
Company assessmentDirect peers
- Divi's Laboratories: Indian-listed API manufacturer and CDMO with similar custom synthesis and intermediates offering for global pharma customers. Direct competitor in the small-molecule API and intermediates CDMO space, with comparable USFDA footprint.
- Laurus Labs: Indian-listed API, intermediates, and CDMO peer serving global pharmaceutical innovators. Comparable business model around custom synthesis, generic APIs, and contract manufacturing with overlapping customer base.
- Syngene International: India-based CRO and CDMO providing contract research and manufacturing services to global pharma and biotech. Closely comparable in CDMO positioning, scientific talent base, and global innovator customer set.
- Jubilant Pharmova: Indian-listed CDMO with API, intermediates, and radiopharmaceuticals manufacturing. Comparable in CDMO service offering, regulatory footprint, and customer profile of global pharmaceutical companies.
- Piramal Pharma Solutions: Contract development and manufacturing arm of Piramal Group offering API and intermediates CDMO services globally. Comparable in integrated CDMO service model targeting innovator pharma customers.
- Suven Pharmaceuticals: Indian CDMO focused on niche APIs, intermediates, and custom synthesis for global pharma. Comparable in CDMO service mix and customer base of innovator and specialty pharmaceutical companies.
- Navin Fluorine International: Indian specialty fluorochemicals manufacturer serving pharma and crop protection customers. Comparable in specialty chemicals custom manufacturing serving overlapping end-markets to Hikal's specialty chemicals and crop protection divisions.
Broad incumbents
- Atul Ltd: Diversified Indian chemical manufacturer with operations spanning specialty chemicals, crop protection, and pharma intermediates. Overlaps with Hikal's specialty chemicals and crop protection business as a broader incumbent in Indian contract/specialty chemicals.
- Aurobindo Pharma: Large Indian generic and API manufacturer with vertically integrated manufacturing. Operates in the same API space as Hikal but with greater downstream formulation exposure; comparable as a broad incumbent in Indian pharmaceutical manufacturing.
- BASF: Global chemical conglomerate with crop protection, intermediates, and custom synthesis businesses. Relevant as a broad incumbent in both crop protection active ingredients and pharmaceutical intermediates where Hikal competes.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Hikal Ltd. social profiles
Digital presenceHikal Ltd. compliance and trust
Trust signalCompliance5 records
Hikal Ltd. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hikal Ltd. leadership team
Management profileNumber of profiles
Profiles3 records
Hikal Ltd. subsidiaries and ownership
Company hierarchySubsidiaries2 records
Hikal Ltd. funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hikal Ltd. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hikal Ltd.
What does Hikal Ltd. do?
Hikal manufactures and supplies active pharmaceutical ingredients (APIs), advanced intermediates, and crop protection chemicals (insecticides, fungicides, herbicides, biocides) for global pharmaceutical, agrochemical, and specialty chemicals companies. The company also provides contract development and manufacturing (CDMO) services, animal health APIs/intermediates, and custom synthesis solutions through five manufacturing facilities and a dedicated Research & Technology centre.
Is Hikal Ltd. a public or private company?
Hikal Ltd. is a public company. It is classified as public and is currently operating.
When was Hikal Ltd. founded?
Hikal Ltd. was founded in 1988. It employs 1,001 to 5,000 people.
Where is Hikal Ltd. based?
Hikal Ltd. is headquartered in Seattle, United States, in the North America region.
How does Hikal Ltd. make money?
Four revenue lines are on record. Pharmaceutical Division is the primary driver. The others are crop Protection Division, specialty Chemicals and contract Research Services.
Who are Hikal Ltd.'s main competitors?
Direct peers on record are Divi's Laboratories, Laurus Labs, Syngene International, Jubilant Pharmova, Piramal Pharma Solutions, Suven Pharmaceuticals and Navin Fluorine International. Broad incumbents are Atul Ltd, Aurobindo Pharma and BASF.
Does Hikal Ltd. have an API?
No public API is recorded for Hikal Ltd..
What industry is Hikal Ltd. in?
Hikal Ltd.'s product category is Pharmaceutical CDMO and Crop Protection Manufacturing. Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of AFABAIAI, Custom Synthesis & Technical Active Ingredient (AI) Manufacturing (intermediates, actives). Its NAICS code is 325411 and its SIC code is 2833.